Richard Sullivan: Cancer control crusaderBMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k1560 (Published 09 May 2018) Cite this as: BMJ 2018;361:k1560
Richard Sullivan, 48, is professor of cancer and global health at King’s College, London, where he combines his interests in national and global cancer policy with wider studies of healthcare systems, particularly in areas of conflict. For nearly a decade he was clinical director of Cancer Research UK, and he worked at the London School of Economics before moving to King’s in 2011. Last year he co-wrote an analysis of David Cameron’s Cancer Drugs Fund, which concluded that it had cost over £1bn and provided relatively small benefits, demonstrating the folly of making policy on the hoof.
What was your earliest ambition?
To become a vet.
What was your best career move?
Joining the Cancer Research …